State-Level Prevalence of Obesity/overweight and Pancreatic Cancer Incidence in the United States: An Ecological Analysis Using BRFSS, CDC WONDER and ACS for the Year 2021.
Sanchit Mehta, Sai Sushrutha Mudupula Vemula, Abdul Aleem, Maria Khakwani, Ahsan Wahab, Karine Tawagi
{"title":"State-Level Prevalence of Obesity/overweight and Pancreatic Cancer Incidence in the United States: An Ecological Analysis Using BRFSS, CDC WONDER and ACS for the Year 2021.","authors":"Sanchit Mehta, Sai Sushrutha Mudupula Vemula, Abdul Aleem, Maria Khakwani, Ahsan Wahab, Karine Tawagi","doi":"10.1007/s12029-026-01562-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>While obesity is established as an individual-level risk factor for pancreatic cancer (PC), population-level associations remain unclear. This study examines whether state-level overweight/obesity (O/OV) prevalence corresponds with age-adjusted PC incidence across the United States.</p><p><strong>Methods: </strong>We conducted an ecological, cross-sectional analysis using 2021 data from the Behavioral Risk Factor Surveillance System (BRFSS) for state-level O/OV prevalence (BMI ≥ 25 kg/m²) and CDC WONDER for age-adjusted incidence rates (AAIR) of PC per 100,000 population. Demographic covariates such as percentage of non-Hispanic Black (NHB) population and population ≥ 65 years old were extracted from American Community Survey (ACS) data. Prevalence of current smokers and diabetes were also extracted from BRFSS. As a descriptive exploratory approach, incidence rate ratios (IRR) were calculated relative to West Virginia (WV) which had the highest O/OV prevalence, 73.6%. For inferential analysis, a univariable ordinary least square (OLS) linear regression was used to determine the association between O/OV prevalence and PC incidence. Multivariable linear regression model was fitted to adjust for prevalence of age ≥ 65, NHB race/ethnicity, current smokers and diabetes prevalence.</p><p><strong>Results: </strong>Across 50 US jurisdictions, including DC, the mean O/OV prevalence was 67.72%, ranging from 55.4% in DC to 73.6% in WV. Florida was excluded from the complete-case analysis and OLS due to missing BRFSS values for O/OV. Twenty-nine states with O/OV prevalence lower than WV also had lower PC incidence (concordance) whereas 20 states including DC exhibited lower O/OV prevalence yet higher PC incidence (discordance). Univariable OLS model showed no statistically significant association between O/OV and AAIR (slope: -0.035, p = 0.56; R²=0.007). Multivariable OLS well fitted model showed no significant association between O/OV and AAIR. Only Black population proportion was significantly associated with PC incidence across the states.</p><p><strong>Conclusions: </strong>In this study, state-level O/OV prevalence failed to demonstrate a statistically significant association with PC incidence. Proportion of Black population was significantly associated with increased PC incidence. These findings suggest that population-level PC risk is likely influenced by multiple interacting metabolic, behavioral, sociodemographic, environmental, and healthcare-related factors beyond obesity alone. Further longitudinal and multivariable studies are needed to better delineate the complex relationship between obesity and PC at the population level.</p>","PeriodicalId":15895,"journal":{"name":"Journal of Gastrointestinal Cancer","volume":"57 1","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastrointestinal Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12029-026-01562-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: While obesity is established as an individual-level risk factor for pancreatic cancer (PC), population-level associations remain unclear. This study examines whether state-level overweight/obesity (O/OV) prevalence corresponds with age-adjusted PC incidence across the United States.
Methods: We conducted an ecological, cross-sectional analysis using 2021 data from the Behavioral Risk Factor Surveillance System (BRFSS) for state-level O/OV prevalence (BMI ≥ 25 kg/m²) and CDC WONDER for age-adjusted incidence rates (AAIR) of PC per 100,000 population. Demographic covariates such as percentage of non-Hispanic Black (NHB) population and population ≥ 65 years old were extracted from American Community Survey (ACS) data. Prevalence of current smokers and diabetes were also extracted from BRFSS. As a descriptive exploratory approach, incidence rate ratios (IRR) were calculated relative to West Virginia (WV) which had the highest O/OV prevalence, 73.6%. For inferential analysis, a univariable ordinary least square (OLS) linear regression was used to determine the association between O/OV prevalence and PC incidence. Multivariable linear regression model was fitted to adjust for prevalence of age ≥ 65, NHB race/ethnicity, current smokers and diabetes prevalence.
Results: Across 50 US jurisdictions, including DC, the mean O/OV prevalence was 67.72%, ranging from 55.4% in DC to 73.6% in WV. Florida was excluded from the complete-case analysis and OLS due to missing BRFSS values for O/OV. Twenty-nine states with O/OV prevalence lower than WV also had lower PC incidence (concordance) whereas 20 states including DC exhibited lower O/OV prevalence yet higher PC incidence (discordance). Univariable OLS model showed no statistically significant association between O/OV and AAIR (slope: -0.035, p = 0.56; R²=0.007). Multivariable OLS well fitted model showed no significant association between O/OV and AAIR. Only Black population proportion was significantly associated with PC incidence across the states.
Conclusions: In this study, state-level O/OV prevalence failed to demonstrate a statistically significant association with PC incidence. Proportion of Black population was significantly associated with increased PC incidence. These findings suggest that population-level PC risk is likely influenced by multiple interacting metabolic, behavioral, sociodemographic, environmental, and healthcare-related factors beyond obesity alone. Further longitudinal and multivariable studies are needed to better delineate the complex relationship between obesity and PC at the population level.
期刊介绍:
The Journal of Gastrointestinal Cancer is a multidisciplinary medium for the publication of novel research pertaining to cancers arising from the gastrointestinal tract.The journal is dedicated to the most rapid publication possible.The journal publishes papers in all relevant fields, emphasizing those studies that are helpful in understanding and treating cancers affecting the esophagus, stomach, liver, gallbladder and biliary tree, pancreas, small bowel, large bowel, rectum, and anus. In addition, the Journal of Gastrointestinal Cancer publishes basic and translational scientific information from studies providing insight into the etiology and progression of cancers affecting these organs. New insights are provided from diverse areas of research such as studies exploring pre-neoplastic states, risk factors, epidemiology, genetics, preclinical therapeutics, surgery, radiation therapy, novel medical therapeutics, clinical trials, and outcome studies.In addition to reports of original clinical and experimental studies, the journal also publishes: case reports, state-of-the-art reviews on topics of immediate interest or importance; invited articles analyzing particular areas of pancreatic research and knowledge; perspectives in which critical evaluation and conflicting opinions about current topics may be expressed; meeting highlights that summarize important points presented at recent meetings; abstracts of symposia and conferences; book reviews; hypotheses; Letters to the Editors; and other items of special interest, including:Complex Cases in GI Oncology: This is a new initiative to provide a forum to review and discuss the history and management of complex and involved gastrointestinal oncology cases. The format will be similar to a teaching case conference where a case vignette is presented and is followed by a series of questions and discussion points. A brief reference list supporting the points made in discussion would be expected.